Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells

被引:0
作者
Daniel J. Craig
Thomas Morrison
Sadik A. Khuder
Erin L. Crawford
Leihong Wu
Joshua Xu
Thomas M. Blomquist
James C. Willey
机构
[1] The University of Toledo College of Medicine,Department of Medicine
[2] Accugenomics,National Center for Toxicological Research
[3] Inc,Department of Pathology
[4] U.S. Food & Drug Administration,undefined
[5] The University of Toledo College of Medicine,undefined
来源
BMC Cancer | / 19卷
关键词
Biomarker; Low-frequency variant detection; Next generation sequencing; Lung Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 227 条
[51]  
Petrick TG(undefined)undefined undefined undefined undefined-undefined
[52]  
Yeo J(undefined)undefined undefined undefined undefined-undefined
[53]  
Crawford EL(undefined)undefined undefined undefined undefined-undefined
[54]  
Zhang X(undefined)undefined undefined undefined undefined-undefined
[55]  
Khuder S(undefined)undefined undefined undefined undefined-undefined
[56]  
Chen T(undefined)undefined undefined undefined undefined-undefined
[57]  
Levin A(undefined)undefined undefined undefined undefined-undefined
[58]  
Tomasetti C(undefined)undefined undefined undefined undefined-undefined
[59]  
Vogelstein B(undefined)undefined undefined undefined undefined-undefined
[60]  
Doll R(undefined)undefined undefined undefined undefined-undefined